Transforming Healthcare with Prevention: A Cost-Effective Strategy

By Staff Writer

October 15, 2023

The Importance of Preventative Measures to Public Health

Both the government of the United Kingdom and the National Health Service (NHS) recognise the significance of prevention work within the medical field. Despite widespread knowledge, people often ignore beneficial preventative strategies. The public health grant has seen a cut of more than a quarter, or 26%, per person since the 2015/2016 fiscal year. This grant covers the delivery of public health services, including preventive measures. The cut has affected its real value. 

Prevention is an investment of public resources that can lower the burden of ill health, strengthen the capacity of the health system, and support economic growth. Prevention is an extremely cost-effective investment. This term refers to the activities one performs to lower the chances of contracting a disease or illness. There are three categories of preventative measures:

  • Primary prevention involves encouraging health before disease develops (for example, through vaccinations);
  • Secondary prevention involves recognising disease at an early stage (through screening programs);
  • Tertiary prevention involves reversing, stopping, or delaying the progression of disease (through chronic disease management programs).

The prevention of poor health is the responsibility of each and every government department, particularly in areas such as the environment, employment, income, education, and crime. Nevertheless, the focus of this paper is on preventative measures that can be taken within the context of the health sector in the UK.

Not only are prevention programs useful for people’s health, but they are also excellent for the economy. According to the findings of a comprehensive analysis, these programs have a return-on-investment ratio of 14 to 1 on average. As a result, budget cuts represent lost chances for the NHS to make savings in terms of both money and capability.

The Economic Impact of Prevention

Preventative measures can lead to significant cost savings. It is expected to cost £3,800 for an additional year of good health through prevention. In contrast, treatment would cost £13,500 for the same period. Moreover, reducing preventable illnesses could potentially increase tax revenue. It could also decrease welfare payments and save costs for the police and criminal justice system.

Preventable illnesses cause the UK economy to lose over £70 billion annually due to lost productivity. A new era of prevention could come if we overcome the obstacles in the way. This could happen through long-term collaboration across parties, innovative financing, and using new opportunities. These opportunities include precision medicine and digital health. 

Stakeholders can make substantial progress towards healthcare prevention goals by taking appropriate actions. Politicians should highlight the social benefits of prevention. The government, health authorities, and partner groups need to devise and execute prevention programs. Integrated care systems should prioritise prevention to benefit local communities and healthcare systems. Healthcare practitioners should prioritise disease prevention within their roles. The industry must innovate more in prevention and focus more on cost-efficient research and therapies. Economists and researchers should broaden the existing information pool and create new tools to facilitate change. The general population must take personal health responsibility to ensure the healthcare system’s sustainability. 

In conclusion, making an investment in preventive can lead to huge rewards, both for one’s health and one’s wallet. It is time for us to shift our attention in the healthcare industry from decision-making and implementation in the short term to decision-making and implementation in the long term.

Reference url

Recent Posts

biosimilars price competition
      

The Impact of MFN Pricing on the U.S. Biosimilar Market

💊 Could MFN Pricing Undermine Biosimilars?

MFN drug pricing aims to cut costs—but its indirect pressure on biosimilars may reduce competition (create a void) and raise long-term prices.

Explore the risks and what stakeholders can do to protect market sustainability.

#SyenzaNews #Biosimilars #DrugPricing #HealthPolicy #Pharma #MarketAccess

EU AI Act Healthcare Compliance
     

Navigating EU AI Act Healthcare Compliance: Proactive Steps for Ethical AI Integration

🔍 Are you prepared for the upcoming EU AI Act in healthcare?

As the first comprehensive AI regulation globally rolls out, healthcare organizations must move beyond mere compliance. The urgency lies in embedding ethical, trusted, and sustainable AI practices into every facet of healthcare AI. Early adoption of ethical assessments and collaboration is essential to navigate the complex regulatory landscape before the August 2026 deadline.

Learn about proactive compliance strategies that not only meet regulatory standards but also enhance patient trust and system efficacy!

#SyenzaNews #AIinHealthcare #HealthcareInnovation #DigitalTransformation

hepatitis vaccine uptake
         

Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists

💉 Are we doing enough to bridge the gap in hepatitis vaccine uptake?

A recent article highlights that while over 90% of children are vaccinated against hepatitis B, adult rates are alarmingly low, posing a significant public health risk. Jeff Goad from the National Foundation for Infectious Diseases emphasizes the crucial role pharmacists can play in increasing access and dispelling common misconceptions about vaccines.

Join the conversation on enhancing vaccination strategies for better health outcomes!

#SyenzaNews #Healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.